Corvus Pharmaceuticals
CRVS
#6346
Rank
โ‚น89.90 B
Marketcap
โ‚น1,066
Share price
7.69%
Change (1 day)
51.98%
Change (1 year)

Corvus Pharmaceuticals (CRVS) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น1.30 Billion

According to Corvus Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น1.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corvus Pharmaceuticals - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น1.00 B9.66%
2021-12-31โ‚น0.91 B-6.5%
2020-12-31โ‚น0.97 B9.48%
2019-12-31โ‚น0.89 B61.9%
2018-12-31โ‚น0.55 B-13.01%
2017-12-31โ‚น0.63 B27.09%
2016-12-31โ‚น0.49 B-94.2%
2015-12-31โ‚น8.60 B970.7%
2014-12-31โ‚น0.80 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น2.20 B 68.00%๐Ÿ‡บ๐Ÿ‡ธ USA